Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Shionogi Secures $36.9 Million Federal Contract for Antibiotic Stockpile to Combat Resistant Infections.
Aug 28, 2026•about 2 hours ago
Contract Type
contract
OsakaBiotechnologyHealth CarePharmaceutical
Description
The federal government has exercised a $36.9 million procurement option for Shionogi's antibiotic, Fetroja, under a contract awarded to its U.S. subsidiary. This marks the initial phase of a larger contract aimed at stockpiling antibiotics for patients with resistant infections.
Company Information
Company
Shionogi & Ltd
Location
Osaka, Osaka Prefecture, Japan
About
Shionogi & Co., Ltd. is a Japanese pharmaceutical company that focuses on the discovery and development of innovative medicines. With a strong commitment to patient needs, Shionogi specializes in treating diseases with significant unmet medical needs. The company emphasizes long-term sustainability and strategic partnerships to enhance its product offerings.